Walk through the packages of almost any Turkish hair transplant clinic and you'll see PRP β Platelet-Rich Plasma therapy β listed as an inclusion or premium add-on. Clinics describe it as accelerating healing, improving graft survival, and stimulating hair growth. But what does the clinical evidence actually say? And if you're choosing between clinics, should PRP inclusion influence your decision?
What PRP Actually Is
PRP therapy involves drawing a small amount of the patient's own blood, processing it in a centrifuge to concentrate the platelet-rich component, and injecting the resulting plasma into the scalp β either into the recipient area post-transplant, the donor area, or both. Platelets contain growth factors including PDGF, VEGF, and IGF-1 that play roles in tissue repair and cell proliferation. The theory is that concentrating these growth factors at the transplant site accelerates healing and improves graft survival rates.
What the Research Shows
The evidence base for PRP in hair transplantation is genuinely mixed. Several randomized controlled trials have shown statistically significant improvements in graft survival rates and early hair density when PRP is used alongside FUE. A 2019 meta-analysis in Dermatologic Surgery found PRP associated with improved hair density and thickness in androgenetic alopecia. However, study quality varies, sample sizes are often small, PRP preparation protocols differ significantly between studies, and not all research shows positive effects. The honest summary: there is meaningful evidence of benefit, but it is not conclusive, and results are likely influenced by preparation technique and individual patient biology.
PRP as Standalone Hair Loss Treatment
Some clinics offer PRP as a standalone treatment for early-stage hair loss (Norwood 1-3) without transplantation. Evidence here is more limited β PRP appears to slow progression and modestly improve density in some patients, but it does not reverse established loss or replace the need for transplantation in patients with significant recession. It is best understood as a complementary treatment rather than a primary intervention.
How to Evaluate PRP Offerings
When a clinic lists PRP as a package inclusion, ask: what concentration protocol do you use, how many tubes of blood are drawn, at what stage of the procedure is PRP applied, and do you have outcome data comparing patients who received PRP vs those who didn't? A clinic that can answer these specifically is using PRP thoughtfully. A clinic that includes it as a marketing bullet point without specifics may be using a low-concentration protocol with limited clinical value. The inclusion of quality PRP in a package is genuinely positive β but it should not be the primary selection criterion.
The Bottom Line
PRP is a legitimate add-on with a plausible mechanism and reasonable supporting evidence. When performed properly with appropriate concentration protocols, it likely provides modest benefits to graft survival and healing speed. It is not transformative, and clinics that lead with PRP as a primary differentiator are somewhat overstating its impact. Prioritize surgeon credentials and clinic accreditation first β then consider PRP quality as a secondary factor.
